AbbVie Spends $10bn On ImmunoGen To Improve Chances In ADC Space

AbbVie Sign
AbbVie is ready to make another play in the ADC space with ImmunoGen deal • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business